ArticleOpen forum infectious diseases2024

Risk of Hepatitis B Reactivation in Patients Receiving Ibrutinib: The National Veterans Affairs Cohort.

Ting-Yi Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.